Related Experiment Video

Updated: Jun 5, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

Peritoneal tuberculosis

A Guirat1, M Koubaa, R Mzali

  • 1Service de chirurgie générale, CHU Habib Bourguiba, 3029 Sfax, Tunisia. ahmedguirat@yahoo.fr

Clinics and Research in Hepatology and Gastroenterology
|January 11, 2011
PubMed

Insights

Peritoneal tuberculosis is a growing global health concern, especially in endemic areas. Diagnosis is challenging, but mycobacterial culture or laparoscopy with biopsy are key, with a 6-month treatment typically effective.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Gastroenterology

Background:

  • Peritoneal tuberculosis (PTB) is an extrapulmonary form of tuberculosis, posing a significant public health challenge globally.
  • Resurgence is linked to migration, immunosuppressive therapy, and the AIDS epidemic.
  • PTB often presents insidiously with varied symptoms, complicating early diagnosis.

Purpose of the Study:

  • To review the clinical, biological, and radiological features of peritoneal tuberculosis.
  • To present current diagnostic methods and treatment strategies for PTB.
  • To highlight the diagnostic challenges and advancements in identifying PTB.

Main Methods:

  • Review of existing literature on peritoneal tuberculosis.
  • Discussion of diagnostic modalities including imaging, biochemical markers, and microbiological tests.
  • Emphasis on microbiological confirmation via ascitic fluid culture or peritoneal biopsy.

Main Results:

  • PTB typically manifests as lymphocytic exudative ascites.
  • Diagnostic accuracy is improved by tests like PCR, adenosine deaminase, interferon-gamma, and BACTEC.
  • Isolation of mycobacteria from ascitic fluid or peritoneal biopsy remains the gold standard for diagnosis.

Conclusions:

  • Peritoneal tuberculosis diagnosis remains challenging due to its subtle presentation and diagnostic test limitations.
  • A combination of clinical suspicion and advanced diagnostic tools can improve detection rates.
  • Standard WHO Group 1 antitubercular therapy for 6 months is generally sufficient for treatment.

Related Concept Videos

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...